7065-97-6 Usage
Uses
Used in Pharmaceutical Industry:
2,3-Quinoxalinebismethanol is used as an intermediate for the synthesis of pharmaceutical compounds, leveraging its potential anti-inflammatory and antibacterial properties to contribute to the development of new medications.
Used in Organic Material Synthesis:
2,3-Quinoxalinebismethanol serves as an intermediate in the synthesis of various organic materials, where its unique chemical structure and properties can be utilized to create novel substances with specific applications.
Used in Industrial Applications:
2,3-Quinoxalinebismethanol is used in the production of coatings and adhesives, where its chemical properties contribute to the performance and quality of these materials in various industrial settings.
Used in Preparation of Bismuth Sodium Ethanoate:
2,3-Quinoxalinebismethanol plays a crucial role in the preparation of bismuth sodium ethanoate, a compound with its own set of applications and benefits in different industries.
Check Digit Verification of cas no
The CAS Registry Mumber 7065-97-6 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 7,0,6 and 5 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 7065-97:
(6*7)+(5*0)+(4*6)+(3*5)+(2*9)+(1*7)=106
106 % 10 = 6
So 7065-97-6 is a valid CAS Registry Number.
InChI:InChI=1/C17H21N3O2S/c1-2-20(15-8-4-3-5-9-15)17-11-10-16(14-18-17)23(21,22)19-12-6-7-13-19/h3-5,8-11,14H,2,6-7,12-13H2,1H3
7065-97-6Relevant academic research and scientific papers
Preparation method of 2, 3-quinoxaline-1, 4-dioxide
-
Paragraph 0008; 0038-0043, (2020/11/09)
The invention discloses a preparation method of 2, 3-quinoxaline-1, 4-dioxide, and belongs to the field of synthesis of medical intermediates. The method comprises the following steps: performing condensation cyclization on 1, 2-phenylenediamine serving as a raw material and 2, 3-butanedione to obtain 2, 3-dimethyl quinoxaline, and oxidizing the 2, 3-dimethyl quinoxaline with hydrogen peroxide under the action of a catalyst to obtain 2, 3-dimethyl quinoxaline-1, 4-dioxide; carrying out rearrangement and hydrolysis on the 2, 3-dimethyl quinoxaline-1, 4-dioxide and acid anhydride to obtain 2, 3-quinoxaline dimethanol; and finally, oxidizing the 2, 3-quinoxaline-1, 4-dioxide with hydrogen peroxide under the action of a catalyst to obtain the 2, 3-quinoxaline-1, 4-dioxide. By adopting the process route, the initial raw materials are easy to obtain, the cost is low, the total yield is as high as 64%, and industrial operation is facilitated.
